WO2024190912A1 - ビタミン臭の抑制方法 - Google Patents
ビタミン臭の抑制方法 Download PDFInfo
- Publication number
- WO2024190912A1 WO2024190912A1 PCT/JP2024/010338 JP2024010338W WO2024190912A1 WO 2024190912 A1 WO2024190912 A1 WO 2024190912A1 JP 2024010338 W JP2024010338 W JP 2024010338W WO 2024190912 A1 WO2024190912 A1 WO 2024190912A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methyl
- odor
- component
- isothiocyanate
- ppt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Definitions
- the present invention relates to a technique for suppressing vitamin odor. Specifically, the present invention relates to a method for suppressing vitamin odor.
- vitamin B1 thiamine
- vitamin B1 can decompose over time, for example in solution, and produce an unpleasant odor specific to vitamin B1. Therefore, there is a demand for the development of technology to suppress such unpleasant odors.
- Patent Documents 1 to 3 For example, techniques have been reported that use various ingredients to suppress such unpleasant odors.
- the present invention aims to provide a technique for suppressing vitamin odor. Specifically, the present invention aims to provide a method for suppressing vitamin odor.
- a composition for suppressing vitamin odor in an object comprising: A composition comprising the following component (A): (A) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol , 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benz
- a composition for the manufacture of an object comprising: A composition comprising the following component (A): (A) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol , 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyanate, citral dimethyl acetal, furfuryl
- composition (specifically, the composition described in [1] or [2]) in which the component (A) is the following component: 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol, At least two components selected from the group consisting of 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyan
- composition (specifically, any one of [1] to [3]) in which the component (A) is the following component (B′′): (B′′) At least one component selected from the group consisting of sclareolide, 2,4-decadienal, citral dimethyl acetal, 3-sulfanylpentan-2-one, and allyl isothiocyanate.
- component (A) is the following component (B′′): (B′′) At least one component selected from the group consisting of sclareolide, 2,4-decadienal, citral dimethyl acetal, 3-sulfanylpentan-2-one, and allyl isothiocyanate.
- the composition specifically, any one of [2] to [4] wherein the target object is an object in which vitamin odor is suppressed.
- the composition (specifically, any one of [1] to [5]) in which the target object contains a component that exhibits a vitamin odor and/or a component that can produce a
- composition in which the component exhibiting a vitamin odor is 2-methyl-3-furanthiol and/or bis(2-methyl-3-furyl)disulfide.
- composition in which the component capable of producing a vitamin odor is vitamin B1.
- composition in which any one of [1] and [3] to [8]) wherein the vitamin odor is a 2-methyl-3-furanthiol odor and/or a bis(2-methyl-3-furyl)disulfide odor.
- composition (specifically, any one of [1] to [9]) wherein the target object is a food or a medicine.
- composition (specifically, any one of [1] to [10]) wherein the object is a food product, and the food product is a beverage.
- a method for suppressing a vitamin odor in an object comprising: A method comprising the steps of: adding the following component (A) to a raw material of an object: (A) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol , 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzen
- a method for manufacturing an object comprising the steps of: A method comprising the steps of: adding the following component (A) to a raw material of an object: (A) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol , 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyan
- the component (A) is the following component: 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol, At least two components selected from the group consisting of 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyan
- a composition comprising a component capable of generating a vitamin odor and/or a component that exhibits a vitamin odor, and the following component (A): (A) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol , 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene is
- composition (specifically, the composition described in [23]) in which the component (A) is the following component: 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol, At least two components selected from the group consisting of 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyanate, citral
- composition (specifically, the composition described in [23]) in which the component (A) is the following component (B′′): (B′′) At least one component selected from the group consisting of sclareolide, 2,4-decadienal, citral dimethyl acetal, 3-sulfanylpentan-2-one, and allyl isothiocyanate.
- component (A) is the following component (B′′): (B′′) At least one component selected from the group consisting of sclareolide, 2,4-decadienal, citral dimethyl acetal, 3-sulfanylpentan-2-one, and allyl isothiocyanate.
- the composition (specifically, any one of [23] to [25]) containing a component capable of producing a component exhibiting a vitamin odor.
- the composition (specifically, any one of [23] to [26]) in which the component capable of producing a vitamin odor is vitamin B1.
- the following component (A) is used as an active ingredient: (A) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol , 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyanate, citral dimethyl acetal, furfuryl thi
- the following component (A') may be used as an active ingredient: (A') at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate, furfuryl thiopropionate, linalyl butyrate, methional, methyl isothiocyanate, nonivamide, sclar
- Component (A') is an example of component (A).
- component (B) may be used as an active ingredient: (B) at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate, citral dimethyl acetal, linalyl butyrate, methyl isothiocyanate, nonivamide, and sclareolide.
- component (B) at least one component selected
- component (B') may be used as an active ingredient: (B') at least one component selected from the group consisting of 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-heptadienal, 2,4-hexadienal, 2-cyclopenten-1-one, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, benzene isocyanate, linalyl butyrate, nonivamide, and sclareolide.
- component (B') at least one component selected from the group consisting of 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-heptadienal, 2,4-hexadienal, 2-cyclopen
- component (B′′) may be used as an active ingredient: (B′′) At least one component selected from the group consisting of sclareolide, 2,4-decadienal, citral dimethyl acetal, 3-sulfanylpentan-2-one, and allyl isothiocyanate.
- Component (B) is an example of component (A).
- Components (B') and (B'') are examples of component (B).
- component (C) may be used as an active ingredient: (C) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophene At least one component selected from the group consisting of thiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyanate, citral dimethyl acetal,
- component (C') may be used as an active ingredient: (C') at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate, furfuryl thiopropionate, methional, methyl isothiocyanate, nonivamide, sclareolide, and S-furfuryl ethanethioate
- Component (C) is an example of component (A).
- Component (C') is an example of component (C).
- Component (A), (A'), (B), (B'), (B"), (C), or (C') is also referred to as the "active ingredient”.
- Component (A), (A'), (B), (B'), (B"), (C), or (C') may be one type of component, or two or more types of components may be used in combination.
- component (A) is 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophene, 2-methyl-3-phenyl-2-butenal ...
- component (B'') may be at least two components selected from the group consisting of sclareolide, 2,4-decadienal, citral dimethyl acetal, 3-sulfanylpentan-2-one, and allyl isothiocyanate.
- Component (A) can be classified, for example, based on its chemical structure as follows: Aldehydes: 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-phenyl-2-butenal, 5-methyl-2-phenyl-2-hexenal, citral dimethyl acetal, and methional.
- Isocyanates ethyl isothiocyanate, 3-(methylthio)propyl isothiocyanate, allyl isothiocyanate, benzene isocyanate, and methyl isothiocyanate.
- Thiols 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, and 3-mercaptohexyl acetate.
- Heterocycles 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-thiophenethiol, furfuryl thiopropionate, and S-furfuryl ethanethioate.
- Esters ethyl linoleate, methyl linolenate, and linalyl butyrate.
- Cyclic carbonyls 2-cyclopenten-1-one, and sclareolide. Vanilloid: Nonivamide.
- the vitamin odor in the target can be suppressed, that is, the effect of suppressing the vitamin odor in the target can be obtained.
- the effect of suppressing the vitamin odor in the target can also be called the “masking effect”.
- the suppression of the vitamin odor in the target can also be simply called “suppression of the vitamin odor”.
- “Suppression of the vitamin odor” can also be called “reduction of the vitamin odor” or “masking of the vitamin odor”.
- “suppression of the vitamin odor” includes both the suppression of the vitamin odor that may occur in the future and the suppression of the vitamin odor that has already occurred.
- “suppression of the vitamin odor” also includes the complete disappearance of the vitamin odor.
- Vitamin odor means the odor that vitamins exhibit. Specifically, by using an active ingredient, the vitamin odor in the target can be suppressed compared to when the active ingredient is not used. Therefore, the masking effect can be determined by comparing and measuring the vitamin odor in the target when the active ingredient is not used and when the active ingredient is used. In other words, it can be determined that the masking effect has been obtained if the intensity of the vitamin odor in the target is smaller when the active ingredient is used compared to when the active ingredient is not used. Measurement and comparison of vitamin odors can be carried out, for example, by sensory evaluation by a specialist panel. The subjects are described below.
- Vitamin odor may mean an unpleasant odor derived from a vitamin.
- the vitamin odor may be generated, for example, by the decomposition of a vitamin.
- vitamin odor may mean, for example, an unpleasant odor that may be generated by the decomposition of a vitamin.
- vitamin odor may mean, for example, an unpleasant odor that is generated by a substance that may be generated by the decomposition of a vitamin. Examples of vitamin decomposition include decomposition of a vitamin by heating and decomposition of a vitamin over time.
- “substances that may be generated by the decomposition of a vitamin” are not limited to substances that may be generated by the decomposition and/or oxidation of the vitamin itself, but also include substances that may be generated by further chemical changes of intermediate substances that may be generated by the decomposition of a vitamin.
- An example of a vitamin is vitamin B1 (thiamine).
- Examples of vitamin odors include 2-methyl-3-furanthiol odor (i.e., the odor generated by 2-methyl-3-furanthiol) and bis(2-methyl-3-furyl)disulfide odor (i.e., the odor generated by bis(2-methyl-3-furyl)disulfide).
- the vitamin odor may be, specifically, for example, 2-methyl-3-furanthiol odor and/or bis(2-methyl-3-furyl)disulfide odor. That is, by utilizing the active ingredient, for example, 2-methyl-3-furanthiol odor and/or bis(2-methyl-3-furyl)disulfide odor may be suppressed. Also, by utilizing component (B), (B'), or (B''), for example, 2-methyl-3-furanthiol odor may be suppressed. In other words, component (B), (B'), or (B'') may be used to suppress 2-methyl-3-furanthiol odor.
- component (C) or (C') for example, bis(2-methyl-3-furyl)disulfide odor may be suppressed.
- component (C) or (C') may be used to suppress bis(2-methyl-3-furyl)disulfide odor.
- Both 2-methyl-3-furanthiol and bis(2-methyl-3-furyl) disulfide can be produced, for example, by the decomposition of vitamin B1 (e.g., decomposition by heating or natural decomposition).
- the active ingredient may be a commercially available product or may be obtained by appropriate manufacturing. There is no particular limitation on the manufacturing method of the active ingredient.
- the active ingredient may be manufactured, for example, by chemical synthesis, enzyme reaction, fermentation, extraction, or a combination thereof.
- the active ingredient may be purified to a desired degree or may not be purified. That is, the active ingredient may be a purified product or a material containing the active ingredient.
- the active ingredient may be, for example, a material containing the active ingredient at 1% (w/w) or more, 5% (w/w) or more, 10% (w/w) or more, 30% (w/w) or more, 50% (w/w) or more, 70% (w/w) or more, 90% (w/w) or more, or 95% (w/w) or more.
- the amount of active ingredient e.g., content (concentration) or amount used
- the amount of active ingredient is calculated based on the amount of the active ingredient itself in the materials.
- composition of the present invention is a composition containing an active ingredient.
- composition of the present invention is a composition containing the following component (A): (A) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol , 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyanate, citral dimethyl acetal, furfuryl thioprop
- composition of the present invention may also be a composition containing the following component (B): (B) at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate, citral dimethyl acetal, linalyl butyrate, methyl isothiocyanate, nonivamide, and sclareolide.
- composition of the invention may in particular be a composition comprising component (B′′): (B′′) At least one component selected from the group consisting of sclareolide, 2,4-decadienal, citral dimethyl acetal, 3-sulfanylpentan-2-one, and allyl isothiocyanate.
- composition of the present invention may also be a composition containing the following component (C): (C) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophene At least one component selected from the group consisting of thiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyanate, citral dimethyl ace
- composition of the present invention may in particular be a composition comprising the following component (C′): (C') at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate, furfuryl thiopropionate, methional, methyl isothiocyanate, nonivamide, sclareolide, and S-furfuryl ethane
- the composition of the present invention may be used to suppress the vitamin odor in an object.
- the composition of the present invention may be, for example, a composition for suppressing the vitamin odor in an object.
- the vitamin odor may be, for example, a 2-methyl-3-furanthiol odor and/or a bis(2-methyl-3-furyl)disulfide odor.
- the composition of the present invention is preferably a composition containing component (B), (B'), or (B''). That is, the composition of the present invention may be, for example, a composition for suppressing the 2-methyl-3-furanthiol odor in an object, containing component (B), (B'), or (B'').
- the composition of the present invention is preferably a composition containing component (C) or (C'). That is, the composition of the present invention may be, for example, a composition for suppressing the bis(2-methyl-3-furyl)disulfide odor in an object, containing component (C) or (C').
- composition of the present invention may be utilized in the manufacture of an object (specifically, in the manufacture of an object having a suppressed vitamin odor). That is, the composition of the present invention may be, for example, a composition for the manufacture of an object (specifically, in the manufacture of an object having a suppressed vitamin odor).
- the object in which the vitamin odor is suppressed may be, for example, an object in which the 2-methyl-3-furanthiol odor and/or the bis(2-methyl-3-furyl)disulfide odor is suppressed.
- the composition of the present invention is preferably a composition containing component (B), (B'), or (B''). That is, the composition of the present invention may be, for example, a composition for producing an object in which the 2-methyl-3-furanthiol odor is suppressed, containing component (B), (B'), or (B'').
- the composition of the present invention is preferably a composition containing component (C) or (C'). That is, the composition of the present invention may be, for example, a composition for producing an object in which the bis(2-methyl-3-furyl)disulfide odor is suppressed, containing component (C) or (C').
- composition of the present invention may be, for example, a seasoning.
- the composition of the present invention may be, for example, a seasoning for suppressing the vitamin odor in an object, or a seasoning for producing an object (specifically, producing an object in which the vitamin odor is suppressed).
- composition of the present invention may be used to suppress the vitamin odor in an object or to manufacture an object in the manner described in the method of the present invention described below.
- composition of the present invention may consist of an active ingredient, or may contain ingredients other than the active ingredient.
- the composition of the present invention may exclude compositions consisting of an active ingredient.
- As the ingredient other than the active ingredient one type of ingredient may be used, or two or more types of ingredients may be used in combination.
- Ingredients other than the active ingredient are not particularly limited as long as they do not impair the masking effect. Ingredients other than the active ingredient can be selected appropriately depending on various conditions, such as the type of target object. Examples of ingredients other than the active ingredient include ingredients that are blended into foods or medicines. Specific examples of ingredients other than the active ingredient include the raw materials of the target object described below.
- ingredients other than the active ingredient include ingredients that can produce a vitamin odor and ingredients that produce a vitamin odor.
- ingredients other than the active ingredient include ingredients that can produce a vitamin odor.
- the composition of the present invention may be a composition that contains, in addition to the active ingredient, an ingredient that can produce a vitamin odor and/or an ingredient that produces a vitamin odor.
- the composition of the present invention may be a composition that contains, in addition to the active ingredient, an ingredient that can produce a vitamin odor.
- the composition of the present invention itself may have the effect of suppressing the vitamin odor.
- the composition of the present invention is a composition that contains, in addition to the active ingredient, a component that can produce a vitamin odor and/or a component that exhibits a vitamin odor
- a component that can produce a vitamin odor and/or a component that exhibits a vitamin odor it is possible to add a component that can produce a vitamin odor and/or a component that exhibits a vitamin odor to the object while suppressing the vitamin odor in the object, thereby making it possible to produce an object that contains a component that can produce a vitamin odor and/or a component that exhibits a vitamin odor.
- the composition of the present invention may be a composition containing a component capable of generating a component exhibiting a vitamin odor and/or a component exhibiting a vitamin odor, and the following component (A): (A) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol , 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal
- the composition of the present invention may be a composition that contains, in particular, a component capable of generating a component exhibiting a vitamin odor and/or a component exhibiting a vitamin odor, and the following component (A′): (A') at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate
- the composition of the present invention may be a composition containing a component capable of generating a component exhibiting a vitamin odor and/or a component exhibiting a vitamin odor, and the following component (B): (B) at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate, citral dimethyl ace
- the composition of the present invention may be a composition that contains, in particular, a component capable of generating a vitamin odor and/or a component that exhibits a vitamin odor, and the following component (B′): (B') at least one component selected from the group consisting of 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-heptadienal, 2,4-hexadienal, 2-cyclopenten-1-one, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, benzene isocyanate, linalyl butyrate, nonivamide, and sclareolide.
- component (B′) at least one component selected from the group consisting of 3-sulfanylpentan-2-one, ethanethioic acid, ethyl iso
- the composition of the present invention may be a composition that contains, in particular, a component capable of generating a vitamin odor and/or a component that exhibits a vitamin odor, and the following component (B′′): (B′′) At least one component selected from the group consisting of sclareolide, 2,4-decadienal, citral dimethyl acetal, 3-sulfanylpentan-2-one, and allyl isothiocyanate.
- the composition of the present invention may be a composition containing a component capable of generating a vitamin odor and/or a component that exhibits a vitamin odor, and the following component (C): (C) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophene At least one component selected from the group consisting of thiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2
- the composition of the present invention may be a composition that contains, in particular, a component capable of generating a component exhibiting a vitamin odor and/or a component exhibiting a vitamin odor, and the following component (C′): (C') at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate, furfuryl thiopropionat
- components that can produce a vitamin odor include vitamins.
- vitamins include vitamin B1 (thiamine).
- components that produce a vitamin odor include components that can be produced by the decomposition of vitamins.
- components that can be produced by the decomposition of vitamins include 2-methyl-3-furanthiol and bis(2-methyl-3-furyl)disulfide.
- the components that produce a vitamin odor may be, for example, 2-methyl-3-furanthiol and/or bis(2-methyl-3-furyl)disulfide.
- the composition of the present invention contains 2-methyl-3-furanthiol
- the composition of the present invention is preferably a composition that contains (B), (B'), or (B'').
- composition of the present invention contains bis(2-methyl-3-furyl)disulfide
- the composition of the present invention is preferably a composition that contains (C) or (C').
- 2-Methyl-3-furanthiol or bis(2-methyl-3-furyl) disulfide can be produced, for example, by decomposition of vitamin B1 (e.g., decomposition by heating or natural decomposition).
- composition of the present invention can be produced, for example, by appropriately mixing the active ingredient and, optionally, other ingredients.
- composition of the present invention may be formulated as appropriate, for example.
- additives may be used as appropriate.
- additives include excipients, binders, disintegrants, lubricants, stabilizers, flavorings, diluents, surfactants, and solvents.
- Additives can be selected as appropriate depending on various conditions, such as the shape of the composition of the present invention.
- the shape of the composition of the present invention is not particularly limited.
- the composition of the present invention may be in any shape, such as a powder, flakes, tablet, paste, liquid, etc.
- the content and content ratio of each component (i.e., the active ingredient and optionally other ingredients) in the composition of the present invention are not particularly limited as long as a masking effect is obtained.
- the content and content ratio of each component in the composition of the present invention can be appropriately set according to various conditions such as the mode of use of the composition of the present invention.
- the content of the active ingredient in the composition of the present invention is greater than 0% (w/w) and less than 100% (w/w).
- the content of the active ingredient in the composition of the present invention is, for example, 0.1 ppt (w/w) or more, 1 ppt (w/w) or more, 10 ppt (w/w) or more, 100 ppt (w/w) or more, 1 ppb (w/w) or more, 10 ppb (w/w) or more, 100 ppb (w/w) or more, 1 ppm (w/w) or more, 10 ppm (w/w) or more, 100 ppm (w/w) or more, 1000 ppm (w/w) or more, 1% (w/w) or more, 2% (w/w) or more, 5% (w/w) or more, or 10% (w /w) or more, or may be 100% (w/w) or less, less than 100% (w/w), 99.9% (w/w)
- the content of the active ingredient in the composition of the present invention may be, for example, 1 ppt (w/w) to 1 ppm (w/w), 1 ppm (w/w) to 10 ppm (w/w), 10 ppm (w/w) to 100 ppm (w/w), 100 ppm (w/w) to 1000 ppm (w/w), 1000 ppm (w/w) to 1% (w/w), 1% (w/w) to 10% (w/w), or 10% (w/w) to 20% (w/w).
- the content of the active ingredient in the composition of the present invention may be, for example, 1 ppt (w/w) to 10% (w/w), 1 ppt (w/w) to 1% (w/w), or 1 ppt (w/w) to 1000 ppm (w/w).
- the "content of the active ingredients in the composition of the present invention” means the total content of those two or more active ingredients in the composition of the present invention, unless otherwise specified.
- the content of those two or more active ingredients in the composition of the present invention may be independently within the range of the content of the active ingredients in the composition of the present invention exemplified above (however, the total content is 100% (w/w) or less).
- each component i.e., the active ingredient and optionally other ingredients
- the content of each component (i.e., the active ingredient and optionally other ingredients) in the composition of the present invention can be set, for example, so as to obtain the amount of each component added in the method of the present invention described below.
- composition of the present invention may be mixed together and contained in the composition of the present invention, or may be contained separately or in any combination.
- the composition of the present invention may be provided as a set of components each packaged separately. In such a case, the components contained in the set may be used together as appropriate when in use.
- the method of the present invention is a method including a step of utilizing an active ingredient.
- the method of the present invention is a method comprising a step of utilizing the following component (A): (A) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol , 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyanate, citral dimethyl acetal, furfurfur
- the method of the present invention may in particular comprise the step of utilizing the following component (A'): (A') at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate, furfuryl thiopropionate, linalyl butyrate, methional, methyl isothiocyanate, nonivamide
- the method of the present invention may also include a step of utilizing the following component (B): (B) at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate, citral dimethyl acetal, linalyl butyrate, methyl isothiocyanate, nonivamide, and sclareolide.
- the method of the present invention may in particular comprise the step of utilizing the following component (B′): (B') at least one component selected from the group consisting of 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-heptadienal, 2,4-hexadienal, 2-cyclopenten-1-one, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, benzene isocyanate, linalyl butyrate, nonivamide, and sclareolide.
- component (B′) at least one component selected from the group consisting of 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-heptadienal, 2,4-
- the method of the present invention may in particular comprise the step of utilizing the following component (B′′): (B′′) At least one component selected from the group consisting of sclareolide, 2,4-decadienal, citral dimethyl acetal, 3-sulfanylpentan-2-one, and allyl isothiocyanate.
- the method of the present invention may also include a step of utilizing the following component (C): (C) 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-decadienal, 2,4-heptadienal, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophene At least one component selected from the group consisting of thiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, benzene isocyanate, citral dimethyl
- the method of the present invention may in particular comprise the step of utilizing the following component (C′): (C') at least one component selected from the group consisting of 2-phenylethanethiol, 3-sulfanylpentan-2-one, ethanethioic acid, ethyl isothiocyanate, ethyl linoleate, 2,4-hexadienal, 2,4-nonadienal, 2-cyclopenten-1-one, 2-mercaptobenzothiazole, 2-methyl-3-furanthiol, 2-phenyl-2-butenal, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, 3-mercaptohexyl acetate, allyl isothiocyanate, benzene isocyanate, furfuryl thiopropionate, methional, methyl isothiocyanate, nonivamide, sclareolide, and S-furfuryl ethan
- the method of the present invention can suppress the vitamin odor in a target object, i.e., a masking effect can be obtained.
- the method of the present invention may be carried out for the vitamin odor in a target object. That is, the method of the present invention may be, for example, a method for suppressing the vitamin odor in a target object. This method is also referred to as the "masking method of the present invention.”
- the vitamin odor may be, for example, a 2-methyl-3-furanthiol odor and/or a bis(2-methyl-3-furyl)disulfide odor.
- the method of the present invention is preferably a method including a step of using component (B), (B'), or (B''). That is, the method of the present invention may be, for example, a method of suppressing a 2-methyl-3-furanthiol odor in a target object, including a step of using component (B), (B'), or (B'').
- the method of the present invention is preferably a method including a step of using component (C) or (C'). That is, the method of the present invention may be, for example, a method of suppressing a bis(2-methyl-3-furyl)disulfide odor in a target object, including a step of using component (B), (B'), or (B'').
- the method of the present invention can produce an object with a suppressed vitamin odor.
- the method of the present invention may be carried out for producing an object (specifically, producing an object with a suppressed vitamin odor). That is, the method of the present invention may be, for example, a method for producing an object (specifically, producing an object with a suppressed vitamin odor). This method is also referred to as the "method of producing an object of the present invention.”
- the object in which the vitamin odor is suppressed may be, for example, an object in which the 2-methyl-3-furanthiol odor and/or bis(2-methyl-3-furyl)disulfide odor is suppressed.
- the method of the present invention is preferably a method including a step of using (B), (B'), or (B''). That is, the method of the present invention may be, for example, a method of producing an object in which the 2-methyl-3-furanthiol odor is suppressed, including a step of using component (B), (B'), or (B'').
- the method of the present invention is preferably a method including a step of using (C) or (C'). That is, the method of the present invention may be, for example, a method of producing an object in which the 2-methyl-3-furanthiol odor is suppressed, including a step of using component (B), (B'), or (B'').
- the active ingredient can be used to suppress the vitamin odor or to manufacture the target object by adding it to the raw materials of the target object during its manufacture. That is, an example of using the active ingredient is to add the active ingredient to the raw materials of the target object. That is, the method of the present invention may specifically be, for example, a method of suppressing the vitamin odor in a target object, which includes adding the active ingredient to the raw materials of the target object. Also, the method of the present invention may specifically be, for example, a method of manufacturing a target object (specifically, manufacturing a target object with a suppressed vitamin odor), which includes adding the active ingredient to the raw materials of the target object. "Adding" is also called "blending.”
- the active ingredient may be utilized in the method of the present invention, for example, in the form of a composition of the present invention. That is, "utilization of an active ingredient” also includes utilization of a composition of the present invention. For example, “addition of an active ingredient” also includes addition of a composition of the present invention.
- the subject obtained by the method of the present invention is also referred to as the "subject of the present invention.”
- the subject of the present invention is a subject in which the vitamin odor is suppressed.
- the subject of the present invention is a subject to which an active ingredient has been added.
- the suppression of vitamin odor or the production of the target product may be carried out in the same manner as the production of a normal target product, except for the use of an active ingredient.
- the suppression of vitamin odor or the production of the target product may be carried out using the same raw materials and under the same production conditions as a normal target product, except for the use of an active ingredient.
- the raw materials and production conditions of the target product may both be modified as appropriate and used for the suppression of vitamin odor or the production of the target product.
- the object is not particularly limited as long as it is something that is taken orally and for which it is desired to suppress the vitamin odor.
- the object may be one that already has a vitamin odor, or one that may have a vitamin odor in the future.
- An example of an object that already has a vitamin odor is an object that contains a component that has a vitamin odor.
- An example of an object that may have a vitamin odor in the future is an object that contains a component that can produce a vitamin odor. That is, the object may contain a component that has a vitamin odor and/or a component that can produce a vitamin odor.
- the components that have a vitamin odor and the components that can produce a vitamin odor are as described above. Examples of components that have a vitamin odor include 2-methyl-3-furanthiol and bis(2-methyl-3-furyl) disulfide.
- An example of a component that can produce a vitamin odor is vitamin B1.
- Examples of the target object include food and medicine.
- Food also includes beverages.
- Food also includes seasonings.
- Food may be liquid or solid, for example.
- Specific examples of food include beverages such as soft drinks, alcoholic drinks, and soups; confectioneries such as jellies, ice cream, candies, cakes, tarts, mousses, bavarois, and gums; processed fruit products such as dried fruits; and seasonings such as dressings, sauces, lemon juice, ponzu sauce, jams, and vegetable creams.
- “Soft drinks” may mean non-alcoholic drinks (drinks with an alcohol concentration of less than 1%) excluding milk and dairy products.
- soft drinks include water, fruit juices, vegetable juices, teas (black tea, etc.), coffee drinks (coffee, etc.), carbonated drinks, sports drinks, jelly drinks, soy milk, and energy drinks.
- Foods are not limited to general foods, but also include so-called health foods or medical foods such as nutritional supplements (supplements), nutritional functional foods, and foods for specified health uses.
- Medicines also include quasi-drugs.
- quasi-drugs include, specifically, nutritional drinks.
- targets in particular, the targets listed above that contain a component that exhibits a vitamin odor and/or a component that can produce a vitamin odor.
- targets in particular, the targets listed above that are manufactured by adding vitamin B1 (for example, a refined product of vitamin B1 or a material that contains vitamin B1).
- the subject may be provided in a form that can be consumed as is, or in a form that requires preparation before or at the time of consumption, such as a concentrated or dried product. "Consuming” may be interpreted as "oral intake” depending on the type of subject.
- the subject may be provided in any container, such as a retort pouch, a paper carton, a plastic bottle such as a PET bottle, a metal can such as a steel can or an aluminum can, or a glass bottle.
- Raw materials for the target object refers to materials for producing the target object.
- raw materials for food refers to food materials for producing food.
- the raw materials for the target object are not particularly limited as long as the target object can be produced.
- the raw materials for the target object can be selected appropriately depending on various conditions such as the type of the target object. Examples of raw materials for the target object include raw materials that can be normally used in the production of the target object, such as those exemplified above.
- raw materials for food include grains such as wheat flour; seasoning ingredients such as sugar, inorganic salts, organic acids, nucleic acids, amino acids, and protein hydrolysates; dairy products such as milk, cheese, and butter; fruits; vegetables; eggs; spices; flavorings; oils and fats; alcohol; dietary fiber; and pH buffers.
- raw materials for pharmaceuticals include additives such as excipients, binders, disintegrants, lubricants, stabilizers, flavorings, diluents, surfactants, and solvents.
- the active ingredient may be added to the raw material of the target product at any stage in the manufacturing process of the target product, as long as a masking effect is obtained.
- the "raw material of the target product" to which the active ingredient is added may be at any stage in the manufacturing process of the target product.
- the "raw material of the target product” to which the active ingredient is added may include the completed target product before the active ingredient is added.
- the active ingredient may be added to the raw material of the target product as is, or after being appropriately prepared into a desired form such as a solution. "Addition of an active ingredient” may collectively refer to the operation of making the active ingredient coexist with the raw material of the target product.
- ingredients other than the active ingredient may also be added to the raw material of the target product as appropriate.
- the description of the addition of an active ingredient may also be applied mutatis mutandis to the addition of ingredients other than the active ingredient.
- the components i.e., the active ingredient and optionally other ingredients
- the order in which the components are added to the raw material of the target product is not particularly limited.
- the amount and ratio of each component (i.e., active ingredient and optionally other ingredients) added in the method of the present invention are not particularly limited as long as a masking effect is obtained.
- the amount and ratio of each component added in the method of the present invention can be appropriately set according to various conditions such as the type of raw material of the target object and the type of target object.
- the active ingredient may be added to the raw material of the target product, for example, so that the ingestible concentration of the active ingredient is within a desired range (for example, the ingestible concentration range of the active ingredient described below).
- the ingested concentration of the active ingredient is, for example, 0.001 ppt (w/w) or more, 0.002 ppt (w/w) or more, 0.005 ppt (w/w) or more, 0.01 ppt (w/w) or more, 0.02 ppt (w/w) or more, 0.05 ppt (w/w) or more, 0.1 ppt (w/w) or more, 0.2 ppt (w/w) or more, 0.5 ppt (w/w) or more, 1 ppt (w/w) or more, 2 ppt (w/w) or more, 5 ppt (w/w) or more, 10 ppt (w/w) or more, 20 ppt (w/w) or more, 50 ppt (w/w) or more, 100 ppt (w/w) or more, 200 ppt (w/w) or more, 500 or more than ppt(w/w), 1 ppb(w/w), 2
- the ingestion concentration of the active ingredient is, for example, 0.001 ppt(w/w) to 0.002 ppt(w/w), 0.002 ppt(w/w) to 0.005 ppt(w/w), 0.005 ppt(w/w) to 0.01 ppt(w/w), 0.01 ppt(w/w) to 0.02 ppt(w/w) ), 0.02 ppt(w/w) ⁇ 0.05 ppt(w/w), 0.05 ppt(w/w) ⁇ 0.1 ppt(w/w), 0.1 ppt(w/w) ⁇ 0.2 ppt(w/w), 0.2 ppt(w/w) ⁇ 0.5 ppt(w/w), 0.5 ppt(w/w) to 1 ppt(w/w), 1 ppt(w/w), 1 ppt(w/w), 1 ppt(w/w), 2 ppt(w/w), 2 ppt(w
- the ingestible concentration of the active ingredient may be, for example, 0.001 ppt (w/w) to 1000 ppm (w/w), 0.01 ppt (w/w) to 100 ppm (w/w), or 0.1 ppt (w/w) to 10 ppm (w/w).
- the "ingestible concentration of the active ingredient” refers to the total ingestible concentration of those two or more active ingredients, unless otherwise specified.
- the ingestible concentrations of those two or more active ingredients may each be independently within the range of the ingestible concentrations of the active ingredients exemplified above.
- the ingested concentration of 3-sulfanylpentan-2-one or 3-mercaptohexyl acetate may be, for example, within the range of the ingested concentrations of the active ingredients exemplified above.
- the ingested concentration of 3-sulfanylpentan-2-one or 3-mercaptohexyl acetate may be, for example, 0.001 ppt (w/w) or more, 0.002 ppt (w/w) or more, 0.005 ppt (w/w) or more, 0.01 ppt (w/w) or more, 0.02 ppt (w/w) or more, 0.05 ppt (w/w) or more, 0.1 ppt ( or more than 0.2 ppt(w/w), or more than 0.5 ppt(w/w), or more than 1 ppt(w/w), or more than 2 ppt(w/w), or more than 5 ppt(w/w), or more than 10 ppt
- the ingestion concentration of 3-sulfanylpentan-2-one or 3-mercaptohexyl acetate may be, for example, 0.001 ppt (w/w) to 1 ppb (w/w), 0.01 ppt (w/w) to 100 ppt (w/w), or 0.1 ppt (w/w) to 10 ppt (w/w).
- the ingested concentration of 2-phenylethanethiol, 2,4-nonadienal, furfuryl thiopropionate, or S-furfuryl ethanethioate may be, for example, within the range of the ingested concentrations of the active ingredients exemplified above.
- the ingested concentration of 2-phenylethanethiol, 2,4-nonadienal, furfuryl thiopropionate, and S-furfuryl ethanethioate may be, for example, 0.01 ppt (w/w) or more, 0.02 ppt (w/w) or more, 0.05 ppt (w/w) or more, 0.1 ppt (w/w) or more, 0.2 ppt (w/w) or more, 0.5 ppt (w/w) or more, 1 ppt(w/w) or more, 2 ppt(w/w) or more, 5 ppt(w/w) or more, 10 ppt(w/w) or more, 20 ppt(w/w) or more, 50 ppt(w/w) or more, 100 ppt(w/w) or more, 200 ppt(w/w) or more, 500 ppt(w/w) or more, 1 ppb(w/w/w
- Concentrations of 2-phenylethanethiol, 2,4-nonadienal, furfuryl thiopropionate, and S-furfurylethanethioate in the diet may be, for example, 0.01 ppt (w/w) to 10 ppb (w/w), 0.1 ppt (w/w) to 1 ppb (w/w), or 1 ppt (w/w) to 100 ppt (w/w).
- the ingested concentration of 2,4-decadienal, 2-methyl-3-furanthiol, or methional may be, for example, within the range of the ingested concentrations of the active ingredients exemplified above.
- the ingested concentration of 2,4-decadienal, 2-methyl-3-furanthiol, or methional may be, for example, 0.1 ppt (w/w) or more, 0.2 ppt (w/w) or more, 0.5 ppt (w/w) or more, 1 ppt (w/w) or more, 2 ppt (w/w) or more, 5 ppt (w/w) or more, 10 ppt (w/w) or more, 20 ppt (w/w) or more.
- 50 ppt(w/w) or more 100 ppt(w/w) or more, 200 ppt(w/w) or more, 500 ppt(w/w) or more, 1 ppb(w/w) or more, 2 ppb(w/w) or more, 5 ppb(w/w) or more, 10 ppb(w/w) or more, 20 ppb(w/w) or more, 50 ppb(w/w) or more, 1 00 ppb(w/w) or more, 200 May be greater than or equal to ppb(w/w), or greater than or equal to 500 ppb(w/w), but not greater than 100 ppb(w/w), not greater than 50 ppb(w/w), not greater than 20 ppb(w/w), not greater than 10 ppb(w/w), not greater than 5 ppb(w/w), not greater than 2 ppb(w/w), not greater than 1 ppb(w/w), not greater than 500
- ingested concentrations of 2,4-decadienal, 2-methyl-3-furanthiol, or methional may be, for example, 0.1 ppt (w/w) to 100 ppb (w/w), 1 ppt (w/w) to 10 ppb (w/w), or 10 ppt (w/w) to 1 ppb (w/w).
- the ingested concentration of ethanethioic acid, 2,4-heptadienal, 2-cyclopenten-1-one, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, benzene isocyanate, linalyl butyrate, or methyl isothiocyanate may be, for example, within the range of the ingested concentrations of the active ingredients exemplified above.
- the ingested concentration of ethanethioic acid, 2,4-heptadienal, 2-cyclopenten-1-one, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, benzene isocyanate, linalyl butyrate, or methyl isothiocyanate may be, for example, 1 ppt (w/w) or more, 2 ppt (w/w) or more, 5 ppt (w/w) or more, 10 ppt (w/w) or more, 20 ppt (w/w) or more, or 30 ppt (w/w) or more.
- the concentration may be not more than 500 ppt (w/w), not more than 2 ppb (w/w), not more than 1 ppb (w/w), not more than 500 ppt (w/w), not more than 200 ppt (w/w), not more than 100 ppt (w/w), not more than 50 ppt (w/w), not more than 20 ppt (w/w), not more than 10 ppt (w/w), not more than 5 ppt (w/w), or not more than 2 ppt (w/w), or any combination thereof that is not contradictory.
- the ingested concentration of ethanethioic acid, 2,4-heptadienal, 2-cyclopenten-1-one, 2-thiophenethiol, 3-(methylthio)propyl isothiocyanate, benzene isocyanate, linalyl butyrate, or methyl isothiocyanate may be, for example, 1 ppt (w/w) to 1 ppm (w/w), 10 ppt (w/w) to 100 ppb (w/w), or 100 ppt (w/w) to 10 ppb (w/w).
- the ingested concentration of ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-hexadienal, 2-mercaptobenzothiazole, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, citral dimethyl acetal, nonivamide, or sclareolide may be, for example, within the range of the ingested concentrations of the active ingredients exemplified above.
- the ingested concentration of ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-hexadienal, 2-mercaptobenzothiazole, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, citral dimethyl acetal, nonivamide, or sclareolide may be, for example, 1 ppt (w/w) or more, 2 ppt (w/w) or more, 5 ppt (w/w) or more, 10 ppt (w/w) or more, 20 ppt (w/w) or more, or 30 ppt (w/w) or more.
- ppt(w/w) or more 50 ppt(w/w) or more, 100 ppt(w/w) or more, 200 ppt(w/w) or more, 500 ppt(w/w) or more, 1 ppb(w/w) or more, 2 ppb(w/w) or more, 5 ppb(w/w) or more, 10 ppb(w/w) or more, 20 ppb(w/w) or more, 50 ppb(w/w) or more, 100 ppb (w/w) or more, 200 ppb (w/w) or more, 300 ppb (w/w) or more, 500 ppb ( It may be 100 ppm(w/w), 50 ppm(w/w), 20 ppm(w/w), 10 ppm(w/w), 5 ppm(w/w), 2 ppm(w/w), 1 ppm(w/w), 500 ppb(w/w), 300 ppb(w/w
- the ingestion concentration of ethyl isothiocyanate, ethyl linoleate, methyl linolenate, 2,4-hexadienal, 2-mercaptobenzothiazole, 5-methyl-2-phenyl-2-hexenal, allyl isothiocyanate, citral dimethyl acetal, nonivamide, or sclareolide may be, for example, 1 ppt (w/w) to 100 ppm (w/w), 10 ppt (w/w) to 10 ppm (w/w), 100 ppt (w/w) to 1 ppm (w/w), or 1 ppb (w/w) to 100 ppb (w/w).
- the ingested concentration of 2-phenyl-2-butenal may be, for example, within the range of the ingested concentrations of the active ingredients exemplified above.
- the ingested concentration of 2-phenyl-2-butenal may be, for example, 100 ppt (w/w) or more, 200 ppt (w/w) or more, 500 ppt (w/w) or more, 1 ppb (w/w) or more, 2 ppb (w/w) or more, 5 ppb (w/w) or more, 10 ppb (w/w) or more, 20 ppb (w/w) or more, 50 ppb (w/w) or more, 100 ppb (w/w) or more, 200 ppb (w/w) or more, 500 ppb (w/w) or more, 1 ppm (w/w) or more, 2 ppm (w/w) or more, 5 ppm (w/w) or more, 10 ppm (w
- the ingested concentration of 2-phenyl-2-butenal may be, for example, 0.1 ppb (w/w) to 100 ppm (w/w), 1 ppb (w/w) to 10 ppm (w/w), or 10 ppb (w/w) to 1 ppm (w/w).
- the ingested concentration of the active ingredient may be, for example, less than the threshold concentration of the active ingredient. Specifically, the ingested concentration of the active ingredient may be, for example, within the range of ingested concentrations of the active ingredient exemplified above, and less than the threshold concentration of the active ingredient.
- “Threshold concentration of the active ingredient” refers to the maximum concentration of the active ingredient at which the odor of the active ingredient itself is not detected when an aqueous solution containing the active ingredient alone is ingested. Examples of the threshold concentration of the active ingredient include the threshold concentrations described in the examples.
- composition of the present invention can be added so as to obtain the amount of the active ingredient exemplified above.
- the subject of the present invention may contain a component (e.g., vitamin B1) that can produce a vitamin odor component. That is, the subject of the present invention may be manufactured to contain a component that can produce a vitamin odor component.
- the subject of the present invention may contain one component that can produce a vitamin odor component, or may contain two or more components.
- the subject containing a component that can produce a vitamin odor component can be manufactured, for example, by adding a component that can produce a vitamin odor component. That is, the method of the present invention may further include adding a component that can produce a vitamin odor component to the raw material of the subject.
- the subject containing a component that can produce a vitamin odor component can be manufactured, for example, by adding the component itself that can produce a vitamin odor component, or by adding a material that contains a component that can produce a vitamin odor component.
- the component that can produce a vitamin odor component may be a commercially available product, or may be obtained by appropriate manufacturing. There are no particular limitations on the method of manufacturing the component that can produce a vitamin odor component.
- the component capable of producing a vitamin odor can be produced, for example, by chemical synthesis, enzyme reaction, fermentation, extraction, or a combination thereof.
- the addition of the component capable of producing a vitamin odor can be carried out in the same manner as the addition of the active ingredient.
- the component capable of producing a vitamin odor may be added to the raw material of the object, for example, so that the content of the component capable of producing a vitamin odor in the object of the present invention is within a desired range (for example, the content range described below).
- the object containing the component capable of producing a vitamin odor can be produced, for example, by using the raw material of the object containing the component capable of producing a vitamin odor. That is, the raw material of the object may contain the component capable of producing a vitamin odor.
- raw materials (particularly food materials) containing vitamin B1 include meats such as pork, beans such as soybeans, grains such as brown rice, and vegetables such as cauliflower and spinach.
- a component capable of producing a vitamin odor When a component capable of producing a vitamin odor can form a salt, the component capable of producing a vitamin odor can be used in its free form, as its salt, or as a combination thereof.
- the term "component capable of producing a vitamin odor” may mean a component capable of producing a vitamin odor in its free form, or its salt, or a combination thereof, unless otherwise specified.
- Free form means a form that does not form a salt.
- a component capable of producing a vitamin odor can form a hydrate
- the component capable of producing a vitamin odor can be used in its non-hydrate form, or its hydrate, or a combination thereof.
- component capable of producing a vitamin odor may include non-hydrates and hydrates, unless otherwise specified.
- the component capable of producing a vitamin odor can be in any form, such as an ion, when used.
- salts with acidic groups such as carboxyl groups
- examples of salts with acidic groups include ammonium salts, salts with alkali metals such as sodium and potassium, salts with alkaline earth metals such as calcium and magnesium, aluminum salts, zinc salts, salts with organic amines such as triethylamine, ethanolamine, morpholine, pyrrolidine, piperidine, piperazine, and dicyclohexylamine, and salts with basic amino acids such as arginine and lysine.
- salts of basic groups such as amino groups include salts with inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, nitric acid, and hydrobromic acid; salts with organic carboxylic acids such as acetic acid, citric acid, benzoic acid, maleic acid, fumaric acid, tartaric acid, succinic acid, tannic acid, butyric acid, hybenzic acid, pamoic acid, enanthic acid, decanoic acid, teoclic acid, salicylic acid, lactic acid, oxalic acid, mandelic acid, malic acid, methylmalonic acid, and adipic acid; and salts with organic sulfonic acids such as methanesulfonic acid, benzenesulfonic acid, and p-toluenesulfonic acid.
- One type of salt may be used, or two or more types of salts may be used in combination.
- the amount of a component that can produce a vitamin odor is calculated based on the amount of the component itself that can produce a vitamin odor in the material when a material containing the component that can produce a vitamin odor is used. Furthermore, when the component that can produce a vitamin odor forms a salt or hydrate, the amount of a component that can produce a vitamin odor (e.g., content (concentration) or amount used) is calculated based on the value obtained by converting the mass of the salt or hydrate into the equimolar mass of the unhydrated free form. The same applies to components that produce a vitamin odor.
- the content of the component that can produce a vitamin odor in the subject matter of the present invention may be, for example, in terms of consumption concentration, 100 ppq (w/w) or more, 200 ppq (w/w) or more, 500 ppq (w/w) or more, 1 ppt (w/w) or more, 2 ppt (w/w) or more, 5 ppt (w/w) or more, 10 ppt (w/w) or more, 20 ppt (w/w) or more, 50 ppt (w/w) or more, 100 ppt (w/w) or more, 200 ppt (w/w).
- a component that can produce a vitamin odor e.g., vitamin B1
- the content of the component that can produce a vitamin odor in the subject matter of the present invention may be, for example, in terms of consumption concentration, 100 ppq (w/w) or more, 200 ppq (w/w) or more, 500 ppq (w/w) or more
- w) or more 500 ppt(w/w) or more, 1 ppb(w/w) or more, 2 ppb(w/w) or more, 5 ppb(w/w) or more, 10 ppb(w/w) or more, 20 ppb(w/w) or more, 50 ppb(w/w) or more, 100 ppb(w/w) or more, 200 ppb(w/w) or more, 500 ppb(w/w) or more, 1 ppm (w/w) or more, 2 ppm (w/w) or more, 5 ppm (w/w) or more, 10 ppm (w/w) or more, 20 ppm (w/w) or more, 50 ppm (w/w) or more, 100 ppm (w/w) or more, 200 It may be greater than or equal to ppm(w/w), or greater than or equal to 500 ppm(w/w), but not greater than 1000 ppm(w/w),
- the concentration may be not more than 10 ppb (w/w), not more than 5 ppb (w/w), not more than 2 ppb (w/w), not more than 1 ppb (w/w), not more than 500 ppt (w/w), not more than 200 ppt (w/w), not more than 100 ppt (w/w), not more than 50 ppt (w/w), not more than 20 ppt (w/w), not more than 10 ppt (w/w), not more than 5 ppt (w/w), not more than 2 ppt (w/w), not more than 1 ppt (w/w), not more than 500 ppq (w/w), or not more than 200 ppq (w/w), or any combination thereof that is not inconsistent.
- the content of a component (e.g., vitamin B1) that may produce a vitamin odor in the subject matter of the present invention may be, specifically, for example, in the form of an ingestible concentration of 100 ppq (w/w) to 200 ppq (w/w), 200 ppq (w/w) to 500 ppq (w/w), 500 ppq (w/w) to 1 ppt (w/w), 1 ppt (w/w) to 2 ppt (w/w), 2 ppt (w/w) to 5 ppt (w/w), 5 ppt (w/w) to 10 ppt (w/w).
- a component e.g., vitamin B1
- the content of a component e.g., vitamin B1 that may produce a vitamin odor in the subject matter of the present invention may be, specifically, for example, in the form of an ingestible concentration of 100 ppq (w/w) to 200 ppq (w/w), 200 ppq (
- the "content of components that can produce a vitamin odor in the object of the present invention” means the total content of those two or more components in the object of the present invention, unless otherwise specified.
- the content of those two or more components in the object of the present invention may be independently within the range of the content of the components that can produce a vitamin odor in the object of the present invention exemplified above.
- the content of vitamin B1 in the object of the present invention may be set within the range of the content of the components that can produce a vitamin odor in the object of the present invention exemplified above.
- the content of components that can produce a vitamin odor in the object of the present invention exemplified above may be read as the sum of the content of the components that can produce a vitamin odor in the object of the present invention and the content of the components that produce a vitamin odor in the object of the present invention.
- the subject matter of the present invention may contain a component that exhibits a vitamin odor (e.g., 2-methyl-3-furanthiol and/or bis(2-methyl-3-furyl)disulfide). That is, the subject matter of the present invention may be manufactured to contain a component that exhibits a vitamin odor.
- the subject matter containing a component that exhibits a vitamin odor can be manufactured, for example, by adding a component that exhibits a vitamin odor. That is, the method of the present invention may further include adding a component that exhibits a vitamin odor to the raw material of the subject matter.
- the subject matter containing a component that exhibits a vitamin odor can be manufactured, for example, by adding the component that exhibits a vitamin odor itself, or by adding a material that contains a component that exhibits a vitamin odor, such as a seasoning that contains a component that exhibits a vitamin odor.
- the component that exhibits a vitamin odor may be a commercially available product, or may be obtained by appropriate manufacturing. There are no particular limitations on the method for manufacturing the component that exhibits a vitamin odor.
- the component that exhibits a vitamin odor can be manufactured, for example, by chemical synthesis, enzyme reaction, fermentation, extraction, or a combination thereof.
- the addition of the component exhibiting a vitamin odor can be carried out in the same manner as the addition of the active ingredient.
- the component exhibiting a vitamin odor may be added to the raw material of the object, for example, so that the content of the component exhibiting a vitamin odor in the object of the present invention is within a desired range (for example, the content range described below).
- the object containing the component exhibiting a vitamin odor can be produced, for example, using the raw material of the object containing the component exhibiting a vitamin odor. That is, the raw material of the object may contain the component exhibiting a vitamin odor.
- the component exhibiting a vitamin odor may be generated, for example, during the manufacturing process of the object of the present invention.
- the component exhibiting a vitamin odor may be generated, for example, by heating a component that can generate a component exhibiting a vitamin odor.
- the method of the present invention may include, for example, a step of heating the raw material of the object or the object containing the component that can generate a component exhibiting a vitamin odor.
- the heating may be carried out before the addition of the active ingredient or after the addition of the active ingredient.
- the component exhibiting a vitamin odor may be generated, for example, after the manufacturing process of the object of the present invention is carried out (for example, during storage of the object of the present invention).
- the heating conditions are not particularly limited as long as a vitamin odor-producing component is produced.
- the heating temperature may be, for example, 50°C or higher, 60°C or higher, 70°C or higher, 80°C or higher, 90°C or higher, or 100°C or higher, or 200°C or lower, 150°C or lower, 120°C or lower, 100°C or lower, 90°C or lower, or 80°C or lower, or any combination thereof that is not contradictory.
- the heating temperature may be, for example, 50 to 200°C, or 80 to 150°C.
- the heating time may be, for example, 1 minute or more, 3 minutes or more, 5 minutes or more, 10 minutes or more, 15 minutes or more, 20 minutes or more, 30 minutes or more, or 60 minutes or more, or 120 minutes or less, 90 minutes or less, 60 minutes or less, or 30 minutes or less, or any combination thereof that is not contradictory.
- the heating time may be, for example, 1 to 120 minutes, 10 to 90 minutes, or 30 to 60 minutes.
- Examples of heating methods include incubating, baking, steaming, boiling, and frying. Heating may be performed, for example, in the presence of moisture. Heating may be performed, for example, in conjunction with the manufacturing process of the object, or may be performed separately from the manufacturing process of the object.
- part of the heating may be performed in conjunction with the manufacturing process of the object, and the rest may be performed separately from the manufacturing process of the object.
- the manufacturing process of the object inherently includes a heating step, the manufacturing process of the object may also perform part or all of the heating.
- the content of the component that exhibits a vitamin odor in the subject matter of the present invention may be, for example, in terms of consumption concentration, 1 ppq (w/w) or more, 2 ppq (w/w) or more, 5 ppq (w/w) or more, 10 ppq (w/w) or more, 20 ppq (w/w) or more, 50 ppq (w/w) or more, 100 ppq (w/w) or more, 200 ppq (w/w) or more, 500 ppq (w/w) or more, 1 ppt (w/w) or more, 2 ppt (w/w) or more, 5 ppt(w/w) or more, 10 ppt(w/w) or more, 20 ppt(w/w) or more,
- the content of components exhibiting a vitamin odor may be, specifically, for example, in the following ingestible concentrations: 1 ppq (w/w) to 2 ppq (w/w), 2 ppq (w/w) to 5 ppq (w/w), 5 ppq (w/w) to 10 ppq (w/w), 10 ppq (w/w) to 20 ppq (w/w), 20 ppq (w/w) to 50 ppq (w/w), 50 ppq (w/w) to 1 00 ppq(w/w), 100 ppq(w/w) ⁇ 200 ppq(w/w), 200 ppq(w/w) ⁇ 500 ppq(w/w), 500 ppq(w/w) ⁇ 1 ppt(w/w), 1 ppt(w/w), 1 ppt(w/w/w), 1 ppt(w/w/w
- the content of the component(s) exhibiting a vitamin odor may specifically be, for example, a concentration for ingestion of 10 ppq (w/w) to 100 ppm (w/w), 1 ppb (w/w) to 100 ppm (w/w), 10 ppb (w/w) to 10 ppm (w/w), or 50 ppb (w/w) to 2 ppm (w/w).
- the content of the components exhibiting a vitamin odor in the subject matter of the present invention means the total content of those two or more components in the subject matter of the present invention, unless otherwise specified.
- the content of those two or more components in the object of the present invention may be each independently within the range of the content of the components that have a vitamin odor in the object of the present invention exemplified above.
- the content of 2-methyl-3-furanthiol or bis(2-methyl-3-furyl) disulfide in the object of the present invention may be set within the range of the content of the components that have a vitamin odor in the object of the present invention exemplified above.
- the present invention also discloses the use of the active ingredient in the above-mentioned applications. That is, the present invention discloses, for example, the use of the active ingredient for suppressing the vitamin odor in an object or for producing an object, and the use of the active ingredient in producing a composition for suppressing the vitamin odor in an object or for producing an object.
- the present invention also discloses active ingredients for use in the applications exemplified above. That is, the present invention discloses, for example, active ingredients for use in suppressing the vitamin odor in an object or in producing an object, and active ingredients for use in producing a composition for suppressing the vitamin odor in an object or in producing an object.
- Example 1 Masking of 2-methyl-3-furanthiol odor First, the effect of masking the odor of 2-methyl-3-furanthiol in an aqueous solution was tested.
- Example 2 Masking of the odor of bis(2-methyl-3-furyl)disulfide First, the effect of masking the odor of bis(2-methyl-3-furyl)disulfide in an aqueous solution was tested.
- Each evaluation sample was prepared by adding each compound shown in Table 3 to a 0.7 ppm aqueous solution of bis(2-methyl-3-furyl)disulfide. The concentration of each compound added was set to a concentration (threshold) at which the odor of the compound itself was not detected when an aqueous solution containing each compound alone was held in the mouth and swallowed.
- Example 3 Masking of 2-methyl-3-furanthiol odor The effect of masking the 2-methyl-3-furanthiol odor in "Aminovital (registered trademark) Jelly Drink Multi-Energy (registered trademark)" (manufactured by Ajinomoto Co., Inc.) (also referred to as "Multi-Energy”) was tested.
- Example 4 Masking of bis(2-methyl-3-furyl)disulfide odor The effect of masking the odor of bis(2-methyl-3-furyl)disulfide in "Multi-Energy” was tested.
- Example 5 Masking of 2-methyl-3-furanthiol odor by combination of active ingredients The masking effect of 2-methyl-3-furanthiol odor in "Multi-Energy” was tested when active ingredients were used alone and when two active ingredients were used in combination.
- Tables 9 and 10 show that sclareolide, 2,4-decadienal, citral dimethyl acetal, 3-sulfanylpentan-2-one, and allyl isothiocyanate, whether used alone or in combination, reduced the intensity of the 2-methyl-3-furanthiol odor, i.e., they demonstrated a masking effect on the 2-methyl-3-furanthiol odor.
- Example 6 Masking the odor of bis(2-methyl-3-furyl)disulfide by a combination of active ingredients The effect of masking the odor of bis(2-methyl-3-furyl)disulfide in "Multi-Energy" was tested when the active ingredients were used alone and when two active ingredients were used in combination.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025507176A JPWO2024190912A1 (cg-RX-API-DMAC7.html) | 2023-03-16 | 2024-03-15 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023042055 | 2023-03-16 | ||
| JP2023-042055 | 2023-03-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2024190912A1 true WO2024190912A1 (ja) | 2024-09-19 |
Family
ID=92755896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2024/010338 Ceased WO2024190912A1 (ja) | 2023-03-16 | 2024-03-15 | ビタミン臭の抑制方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2024190912A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024190912A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN122139766A (zh) * | 2026-05-09 | 2026-06-05 | 山东农业大学 | 一种蔬菜抑芽剂的使用方法及应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018181630A1 (ja) * | 2017-03-29 | 2018-10-04 | 味の素株式会社 | 焼けた油の風味を付与するための組成物 |
| WO2021193429A1 (ja) * | 2020-03-26 | 2021-09-30 | 味の素株式会社 | マスキング剤 |
-
2024
- 2024-03-15 JP JP2025507176A patent/JPWO2024190912A1/ja active Pending
- 2024-03-15 WO PCT/JP2024/010338 patent/WO2024190912A1/ja not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018181630A1 (ja) * | 2017-03-29 | 2018-10-04 | 味の素株式会社 | 焼けた油の風味を付与するための組成物 |
| WO2021193429A1 (ja) * | 2020-03-26 | 2021-09-30 | 味の素株式会社 | マスキング剤 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN122139766A (zh) * | 2026-05-09 | 2026-06-05 | 山东农业大学 | 一种蔬菜抑芽剂的使用方法及应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2024190912A1 (cg-RX-API-DMAC7.html) | 2024-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2830440B1 (en) | N-acyl-aminocyclopropyl carboxylic acids as food flavouring compounds | |
| US12575590B2 (en) | Masking agent | |
| US9167836B2 (en) | Perfume composition | |
| JP7388468B2 (ja) | 味質向上剤 | |
| EP4473846A1 (en) | Method for suppressing p-cresol odor | |
| JP2010528595A (ja) | 食品用酸化防止剤 | |
| JP7119395B2 (ja) | オフフレーバーの抑制方法 | |
| JP2022170686A (ja) | 酸味・酸臭の抑制剤 | |
| JP6753618B2 (ja) | 血中中性脂肪上昇抑制組成物 | |
| JP2020186264A (ja) | 血中中性脂肪上昇抑制組成物 | |
| JP7290369B2 (ja) | 血中中性脂肪上昇抑制組成物 | |
| JP2017001966A (ja) | 血中中性脂肪上昇抑制組成物 | |
| WO2025013866A1 (ja) | レモン劣化臭の抑制方法 | |
| JP5911202B2 (ja) | 香料組成物 | |
| WO2023008377A1 (ja) | 呈味と香りが向上した飲食品 | |
| WO2022138890A1 (ja) | 香料組成物 | |
| JP2025010947A (ja) | 2,6-ジメチルピリジン臭の抑制方法 | |
| JP7547717B2 (ja) | 乳タンパク風味改善剤及び乳タンパク風味改善効果を有する新規化合物 | |
| KR20190100877A (ko) | 식품, 향미료 및 식품의 제조 방법, 및 식품에 향미를 부여하는 방법 | |
| JP2025010929A (ja) | 4-エチルグアヤコール臭の抑制方法 | |
| JP2025147044A (ja) | 血中中性脂肪上昇抑制組成物 | |
| JP4848433B2 (ja) | 香料組成物 | |
| JP2024144332A (ja) | 酸味及び/又は酸臭抑制用組成物 | |
| JP2025124037A (ja) | 大豆由来食材の異臭低減用組成物 | |
| WO2024202499A1 (ja) | 加熱済み調味用組成物及び風味付与用組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24771014 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2025507176 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 24771014 Country of ref document: EP Kind code of ref document: A1 |